Pfizer Inc. (NYSE:PFE) has begun testing an over-the-counter version of Lipitor, the blockbuster drug that has plumped up the pharmaceutical giant’s coffers for more than a decade. Pfizer Inc. (NYSE:PFE) stock performance was 2.22% in last session and finished the day at $32.69. Traded volume was 26,325,091 million shares in the last session and the average volume of the stock remained 26.27 million shares. The beta of the stock remained 0.69. Pfizer Inc. (NYSE:PFE) insider ownership is 0.02%.

Novavax, Inc. (NASDAQ:NVAX) announced that it will host a conference call and webcast to report its fourth quarter and year-end 2013 financial results on Monday, March 10, 2014, at 4:30 p.m. ET. Novavax, Inc. (NASDAQ:NVAX) rose 1.27 percent to $6.38 yesterday on volume of 13.48 million shares. The intra-day range of the stock was $6.28 to $6.55. Novavax, Inc. (NASDAQ:NVAX) has a market capitalization of $1.33 million.

Boston Scientific Corp. (NYSE:BSX)‘s stock had its “neutral” rating reaffirmed by Zacks in a research report issued to clients and investors on Tuesday, ARN reports. Boston Scientific Corporation (NYSE:BSX)’s stock on Mar 4, 2014 reported a increase of 1.77% to the closing price of $13.23. Its fifty two weeks range is $7.07 -$14.08. The total market capitalization recorded $17.52 billion. The overall volume in the last trading session was 13,015,236 million shares. In its share capital, Boston Scientific Corporation (NYSE:BSX) has 1.33 million outstanding shares.

Trade-Ideas LLC identified Dendreon Corporation (NASDAQ:DNDN) as a “perilous reversal” (up big yesterday but down big today) candidate. On Tuesday, shares of Dendreon Corporation (NASDAQ:DNDN) dropped -7.25% to close the day at $3.07. Company return on investment (ROI) is -55.10% and its monthly performance is recorded as 10.04%. Dendreon Corporation (NASDAQ:DNDN) quarterly revenue growth is 3.37%.